nature neurOSCIenCe a r t I C l e S RGPs are responsible for generating nearly all cortical excitatory neurons during embryonic development 1 . They reside in the VZ, a germinal zone of the developing cortex, and possess a short apical process that anchors at the VZ surface (ventricular endfoot) and a long basal process that reaches the pia (radial glial process). During embryonic cortical development, RGPs undergo extensive divisions at the VZ surface to produce neurons either directly or indirectly via transient amplifying progenitors, such as intermediate progenitors (IPs, also called basal progenitors) 2-4 , outer subventricular zone (OSVZ) radial glial progenitors (oRGs, also called OSVZ progenitors, intermediate RGs or translocating RGs (tRGs)) 5-10 and short neural precursors 11 . Successive waves of neurogenesis and coordinated neuronal migration lead to a stereotypic 'inside-out' sequence of lamina formation in the cortex 12 , the largest brain structure that supports all high-order brain functions.
a r t I C l e S RGPs are responsible for generating nearly all cortical excitatory neurons during embryonic development 1 . They reside in the VZ, a germinal zone of the developing cortex, and possess a short apical process that anchors at the VZ surface (ventricular endfoot) and a long basal process that reaches the pia (radial glial process). During embryonic cortical development, RGPs undergo extensive divisions at the VZ surface to produce neurons either directly or indirectly via transient amplifying progenitors, such as intermediate progenitors (IPs, also called basal progenitors) [2] [3] [4] , outer subventricular zone (OSVZ) radial glial progenitors (oRGs, also called OSVZ progenitors, intermediate RGs or translocating RGs (tRGs)) 5-10 and short neural precursors 11 . Successive waves of neurogenesis and coordinated neuronal migration lead to a stereotypic 'inside-out' sequence of lamina formation in the cortex 12 , the largest brain structure that supports all high-order brain functions.
The centrosome is a cellular organelle in animals that serves as the main microtubule-organizing center (MTOC) and provides the basal body that acts as a template for cilia and flagella assembly [13] [14] [15] . It is composed of a core of two centrioles surrounded by a mass of proteins known as the pericentriolar material. Mutations in centrosomal proteins have been linked to human autosomal recessive primary microcephaly (MCPH), a neurodevelopmental disorder that is characterized by small brain size and deficient neuronal production in the cortex 16, 17 . Although centrosomal proteins are ubiquitously expressed, the selective vulnerability of cortical development demonstrates the importance of an intact centrosome in cortical neurogenesis. A number of mouse models with mutations in centrosomal proteins have been established and characterized [18] [19] [20] . However, the precise functions of the centriole, along with the centrosome in actively dividing RGPs and the centrosome-related cell biological roots of MCPH remain elusive.
To define the functions of centrioles and centrosomes in RGPs, we used a conditional null allele to delete Sas-4 (also known as Cenpj, or, CPAP and MCPH6 in humans) 21 , which encodes a protein required for centriole biogenesis [22] [23] [24] [25] , in the developing mouse brain. As expected, removal of SAS-4 in RGPs led to a progressive loss of centrioles and centrosomes. This resulted in p53 upregulation and widespread cell death of progenitors, leading to a substantial loss of neurons and microcephaly. Simultaneous removal of p53 fully rescued the Sas-4 conditional mutant from microcephaly. Further analysis revealed that the microcephaly arose largely from the preferential apoptosis of RGPs delocalized from the VZ as a result of the loss of centrosomes. Although RGPs in the Sas-4 −/− ; p53 −/− double mutant brain became ectopically localized and divided with randomly oriented mitotic spindles, they retained full neurogenic potential and generated the normal number of neurons. These results suggest that the key functions of the centrosome in cortical neurogenesis are to anchor RGPs in the VZ, to facilitate the formation of the mitotic spindle, and prevent activation of p53 and cell death. Our data suggest that RGPs have a surprising plasticity in the developing cortex in vivo and challenge prevailing views of the importance of mitotic spindle orientation and progenitor localization to the VZ in cortical neurogenesis.
RESULTS

Sas-4 deletion causes p53-dependent microcephaly
Mutations in the SAS-4/CENPJ gene cause microcephaly in humans 26 . Mouse embryos that completely lack Sas-4 die at mid-gestation around embryonic (E) day 8.5, as a result of massive p53-dependent cell death 21 . To define the function of centrioles in cortical neurogenesis and the cell biological basis of centrosome-associated microcephaly, we selectively removed Sas-4 from neural progenitors beginning at ~E10-11 by crossing mice carrying a conditional null allele of Sas-4 with mice carrying Nestin-Cre 27 (Supplementary Fig. 1a ). This led to a marked decrease in the amount of SAS-4 in the developing brain at E13.5 (Supplementary Fig. 2a ). The conditional Sas-4 mutants showed a strong microcephalic phenotype that was obvious by E15.5 a r t I C l e S ( Fig. 1a and Supplementary Fig. 2b) . Compared with wild-type (WT) littermate controls, the telencephalic area estimated by circumference measurement of Sas-4 −/− mice was reduced by ~38 ± 5% at this stage (WT, n = 4 brains; Sas-4 −/− , n = 4 brains; P < 0.01).
To pinpoint the origins of microcephaly, we examined cortical organization and cell death by assessing cleaved caspase 3 (CASP3) and p53 expression ( Fig. 1) . Although there was no apparent difference in cortical organization or cell death between WT and Sas-4 −/− mice at E12.5 (Fig. 1b,c) , p53 was clearly upregulated in the Sas-4 −/− , but not WT, cortex (Fig. 1b,c) , suggesting that an apoptosis cascade is initiated in the Sas-4 −/− cortex at E12.5. Indeed, apoptosis was evident 1 d later at E13.5 and progressively increased as time passed ( Fig. 1d-g) . By E15.5, extensive p53 upregulation and apoptosis were observed in the VZ, the SVZ and the intermediate zone (IZ), but not in the cortical plate (CP), of the mutant cortex ( Fig. 1h,i) .
To test whether the upregulation of p53 was responsible for the cell death and microcephaly, we analyzed cortical development in mice with simultaneous conditional deletion of both p53 and Sas-4 in neural progenitors using Nestin-Cre (Fig. 2) . The telencephalic area of Sas-4 −/− ; p53 −/− mice was indistinguishable from that of WT mice at E15.5, postnatal (P) day 1 and P14 ( Fig. 2a, Fig. 2b ) and no obvious apoptosis was detected in the Sas-4 −/− ; p53 −/− cortex ( Supplementary Fig. 2c ), indicating that removal of p53 suppressed apoptosis and fully rescued the microcephaly caused by Sas-4 deletion. Conditional deletion of p53 alone using Nestin-Cre did not cause any obvious defects in progenitor behavior and neurogenesis in the developing cortex ( Supplementary Fig. 3 ), as suggested previously 20 .
b,f and Supplementary
Because the cortex develops in a birth date-dependent inside-out sequence, in which neurons born at later times migrate past earlierborn neurons and occupy superficial positions 12 , we examined the identity of neurons that were lost in the Sas-4 −/− cortex. Compared with the WT control, the number of early-born CTIP2-expressing deep layer neurons 28 was not obviously changed, but the number of late-born CUX1-expressing superficial layer neurons 28 was reduced by ~41% in the Sas-4 −/− cortex ( Fig. 2c-e ). The preferential loss of the superficial, but not deep, layer neurons most probably reflects the progressive loss of centrioles and appearance of apoptotic cells following SAS-4 removal ( Fig. 1c-j) ; that is, apoptosis mostly occurs when the superficial layer neurons are produced. Moreover, the neuronal loss and microcephaly in Sas-4 −/− mice were not a result of a loss of primary cilia, as there was no detectable apoptosis, neuronal loss or microcephaly in the conditional Ift88 −/− brain that lacked primary cilia ( Supplementary Fig. 4) .
Notably, removal of p53 completely restored the superficial layer neurons lost in the Sas-4 −/− cortex. The thickness and cell number of the superficial layers marked by CUX1 in the Sas-4 −/− ; p53 −/− cortex were not obviously different from those of the WT control at P1 ( Fig. 2c-e ) and P14 ( Fig. 2g-i) . These results suggest that Sas-4 −/− cells in the developing cortex retain the ability to generate the correct number and type of neurons if they are rescued from apoptosis by removal of p53. Notably, we observed a minor, but substantial, population of CUX1-expressing neurons located in the deep layers ( Fig. 2g and Supplementary Fig. 5a ) as well as a small heterotopia in the posterior dorsomedial region of the Sas-4 −/− ; p53 −/− cortex ( Supplementary Fig. 6 ), indicating that there were subtle defects in cortical neuronal migration. There was no obvious change in the number or distribution of neurons expressing FOXP2 and SATB2 (Supplementary Fig. 5b,c) , two other cortical neuronal markers 28 . In addition, similar to the Ift88 −/− brain ( Supplementary Fig. 7) , the Sas-4 −/− ; p53 −/− brain showed hydrocephalus ( Supplementary  Fig. 7 ) and cerebellar hypoplasia ( Fig. 2f) , likely as a result of the loss of cilia (see below) 29 .
Microcephaly arises from a loss of displaced progenitors
Cell death in the embryonic cortex of Sas-4 −/− mice was most prominent in the regions in which progenitors reside ( Fig. 1e-j ). There are two major populations of progenitors in the developing mouse cortex: PAX6-expressing RGPs located in the VZ and TBR2-expressing IPs in the SVZ 4 . We detected, in the Sas-4 −/− cortex, p53 expression exclusively in proliferating cells expressing Ki67 ( Supplementary  Fig. 8a,b) , and mostly in PAX6-expressing cells ( Supplementary  Fig. 8c,d) . Compared with the WT control at E15.5, the total number of PAX6-expressing cells was markedly reduced in the Sas-4 −/− cortex ( Fig. 3a,b ). In addition, some PAX6-expressing cells were located in npg a r t I C l e S the SVZ and the IZ instead of their normal position in the VZ. TBR2expressing IPs exhibited a similar reduction in number in the Sas-4 −/− cortex in the SVZ (Fig. 3c,d) .
We then examined progenitors in the Sas-4 −/− ; p53 −/− brain, which did not show microcephaly. Although the number of PAX6-expressing cells in the Sas-4 −/− ; p53 −/− VZ was comparable to that in the Sas-4 −/− cortex ( Fig. 3a,b) , there was an additional large population of ectopic PAX6-expressing cells that were mostly located in the IZ (Fig. 3a) . Consequently, the total number of PAX6-expressing cells in the Sas-4 −/− ; p53 −/− cortex was indistinguishable from that in the WT control ( Fig. 3a,b) . Moreover, similar to those located in the VZ, virtually all ectopic PAX6-expressing cells were positive for SOX2 ( Supplementary Fig. 9a,b) , another transcription factor expressed in RGPs 30 , and brain lipid-binding protein (BLBP; Supplementary  Fig. 9c,d) , a bona fide RGP marker 31 , further suggesting that they are 'RGP' in nature.
Similarly, the total number of TBR2-expressing IPs in the Sas-4 −/− ; p53 −/− cortex was comparable to that in the WT control, but was substantially more than that in the Sas-4 −/− cortex. Most of the additional IPs were located ectopically in the IZ (Fig. 3c,d) . Given that there was no obvious displacement of IPs away from the SVZ in the Sas-4 −/− cortex, the ectopic IPs in the Sas-4 −/− ; p53 −/− cortex most probably originated from displaced RGPs that were rescued from apoptosis. Notably, we obtained similar results in progenitor delocalization and loss, and microcephaly when we used an Emx1-Cre allele 32 (Supplementary Fig. 1b ) to delete Sas-4 alone or Sas-4 and p53 in the cortex (Supplementary Fig. 10 ). Together, these results strongly suggest that neuronal loss and microcephaly in the Sas-4 −/− brain arise primarily from the loss of ectopically localized RGPs and their IP progeny.
Centrosome loss leads to delocalization of RGPs
Consistent with the essential role of SAS-4 in centriole biogenesis [22] [23] [24] [25] , we observed a progressive loss of centrosomes, as well as a depletion of the primary cilia that grow from the functional centrioles, in the Sas-4 −/− cortex, as revealed by staining for pericentrin (PCNT), a pericentriolar material protein, and ARL13B, a marker of the primary cilia 33 . The loss of centrosomes and primary cilia outside of the VZ surface (extra-VZ) was clear by E12.5 ( Supplementary Fig. 11a,b) . In contrast, the loss of centrosomes and primary cilia at the VZ surface, where the centrosomes of RGPs normally reside 34, 35 , was not obvious until E14.5 ( Supplementary Fig. 11a,b) . These results suggest that Consistent with this notion, although there was a substantial number of ARL13B-labeled primary cilia at the VZ surface associated with RGPs in the VZ in the Sas-4 −/− ; p53 −/− cortex at E1.5.5, there were virtually no primary cilia detected in ectopically localized PAX6-expressing cells (Fig. 4a) , indicating a lack of the centriole/centrosome in displaced RGPs. Together, these results suggest that centriole/ centrosome loss causes RGPs to delocalize from the VZ.
Delocalized RGPs are not oRGs and remain proliferative A small number of RGP-like progenitors have been found outside the VZ of the rodent cortex [5] [6] [7] . They retain the basal process to the pia, but lack the apical process to the ventricular surface. To test whether delocalized RGPs become oRGs, we examined the morphology of delocalized RGPs in the Sas-4 −/− ; p53 −/− cortex. We injected retroviruses expressing enhanced GFP (EGFP) into the lateral ventricle of WT and Sas-4 −/− ; p53 −/− embryos at E11.5 to label dividing RGPs at the VZ surface and their progeny. Brains were recovered at E15.5 for analysis. npg a r t I C l e S Although EGFP-expressing cells positive for PAX6 were frequently observed in the VZ of WT cortex (Fig. 4b) , they were rarely found in the VZ of Sas-4 −/− ; p53 −/− cortex; instead, they were predominantly located outside of the VZ (Fig. 4b) , consistent with a delocalization of RGPs in Sas-4 −/− ; p53 −/− cortex. As expected, the PAX6-expressing RGPs in the VZ of WT cortex displayed a characteristic bipolar morphology (Fig. 4b,c) . In contrast, most of the PAX6-expressing cells outside of the VZ in Sas-4 −/− ; p53 −/− cortex exhibited a multipolar morphology with several short processes emanating from the cell body (Fig. 4b,c) . Similar morphological features were revealed by BLBP labeling (Supplementary Fig. 9e ). Moreover, although PAX6-expressing cells in the VZ were readily labeled by the lipophilic dye DiI applied at the pia, those in the extra-VZ were rarely labeled ( Supplementary Fig. 12a,b) , suggesting that the majority of ectopic PAX6-expressing cells in the Sas-4 −/− ; p53 −/− cortex do not possess a pia-reaching basal process. Consistent with a lack of the long basal process, we observed mitotic EGFP-and PAX6-expressing cells outside of the VZ labeled by phosphorylated VIMENTIN (P-VIMENTIN) 36 as rounded cells with no discernible pia-directed process ( Supplementary  Fig. 12c ). Together, these results suggest that delocalized RGPs originate from dividing RGPs in the VZ; however, they are largely multipolar in morphology, without a prominent basal process and are therefore not oRGs.
The VZ is considered to be a niche for RGPs 37 and detachment of RGPs from the VZ has been associated with premature differentiation 35, 38 . However, we found that, similar to control RGPs in the VZ of WT cortex, PAX6-expressing RGPs in Sas-4 −/− ; p53 −/− cortex, regardless of their localization in or out of the VZ, expressed the proliferation marker Ki67 (Fig. 5a) . Moreover, we observed numerous mitotic cells labeled with phosphorylated histone H3 (PHH3) or P-VIMENTIN both at and away from the VZ surface ( Fig. 5b-e ). In fact, there was a substantial increase in the number of M-phase cells in Sas-4 −/− ; p53 −/− cortex compared with WT control. These results clearly suggest that delocalized RGPs lacking the centriole/ centrosome remain proliferative and do not prematurely exit the cell cycle and differentiate.
Centrosome loss results in mitotic delay
Loss of centrioles/centrosomes has been reported to cause mitotic spindle assembly defects and delays in mitotic progression 39 . Given that there was no increase in the total number of progenitors in the Sas-4 −/− ; p53 −/− cortex (Fig. 3) , the increase in mitotic cells ( Fig. 5b-e ) indicates that the mitotic progression of Sas-4 −/− ; p53 −/− progenitors is affected. To test this, we analyzed the fraction of dividing cells in metaphase, anaphase or telophase (meta/ana/telophase) versus those in prophase or pro-metaphase (pro/pro-metaphase), which reflects mitotic progression. Dividing cells were identified by their expression of P-VIMENTIN and their mitotic phase was inferred from the arrangement of chromosomes (Fig. 6a) . We found that, in the WT cortex, the fraction of mitotic cells in pro/pro-metaphase was ~55% both at the VZ surface and away from the VZ surface (Fig. 6a,b) . In contrast, this fraction increased to ~80% for cells in the Sas-4 −/− ; p53 −/− cortex that divided at the VZ surface and to ~86% for cells that divided away from the VZ surface (Fig. 6a,b) . These results suggest that the duration of pro/pro-metaphase is prolonged in centriole-deficient mitotic progenitors lacking SAS-4. Consistent with a delay in mitotic progression, we observed a clear increase in the number of proliferative cells labeled by Ki67 (Supplementary npg a r t I C l e S Fig. 13a,b) , but no obvious change in the cell cycle exit ( Supplementary  Fig. 13a,c) , in Sas-4 −/− ; p53 −/− cortex. We then examined the spindle pole status in mitotic cells by staining them with the antibody to PCNT. Although the mitotic cells in the WT cortex contained two prominent PCNT foci (Fig. 6c,d) , those in the Sas-4 −/− ; p53 −/− cortex exhibited a clear deficit of the PCNT foci ( Fig. 6c,d) . Specifically, the mitotic cells at the VZ surface mostly contained only one PCNT focus, whereas those away from the VZ surface possessed either none or only one PCNT focus. These results suggest that mitotic progenitors lacking SAS-4 exhibit defects in spindle pole assembly, which likely trigger mitotic delay, and subsequent p53 upregulation and apoptosis. It is important to note that there was no neuronal loss or microcephaly in the Sas-4 −/− ; p53 −/− cortex, suggesting that the mitosis of centriole-deficient progenitors lacking SAS-4 does proceed to completion, should apoptosis be prevented. Moreover, analysis of the chromosome number by fluorescence in situ hybridization revealed that there was no substantial increase in aneuploidy in the Sas-4 −/− ; p53 −/− cortex when compared with the control (Supplementary Fig. 14a,b) . Consistent with this, we did not observe any dividing cells with multipolar spindles or lagging chromosomes in the Sas-4 −/− ; p53 −/− cortex (Supplementary Fig. 14c,d) . In addition, no substantial increase in DNA damage was observed, as revealed by γ-H2AX expression ( Supplementary Fig. 14e,f) . Similarly, no obvious increase in aneuploidy or DNA damage was detected in Sas-4 null embryos at mid-gestation 21 .
Proliferation of delocalized RGPs
An important feature of RGPs during cortical neurogenesis is their ability to undergo consecutive rounds of mitosis. This is achieved through asymmetric cell division that renews the RGPs while producing neurons or transient amplifying progenitors 2, 3 . To test whether ectopically localized RGPs are capable of self-renewing, we performed sequential pulse-chase experiments using 5-bromo-2′-deoxyuridine (BrdU) and 5-ethynyl-2′-deoxyuridine (EdU), two thymidine analogs, spaced 24 h apart (Fig. 7a) . If a progenitor goes through S-phase more than once during this period, it should incorporate both BrdU and EdU. Notably, similar to PAX6-expressing RGPs in the VZ of control cortex (Fig. 7a,b) , ectopically localized BLBP-and PAX6-expressing cells in Sas-4 −/− ; p53 −/− cortex expressed both BrdU and EdU (Fig. 7a,b and Supplementary Fig. 15 ), suggesting that these delocalized RGPs actively divide and self-renew outside of the VZ niche.
The centrosomes at the mitotic spindle poles are likely important for controlling the position of the mitotic spindle, and thus the cleavage plane orientation [40] [41] [42] . We therefore analyzed the cleavage plane orientation of dividing progenitors both at and away from the VZ surface in Sas-4 −/− ; p53 −/− cortex. Because the metaphase plate of dividing progenitors in the cortex rocks extensively and is not set until anaphase 43, 44 , we focused on progenitors at ana/ telophase, as revealed by P-VIMENTIN staining and chromosomal arrangement (Fig. 7c) . We assessed the cleavage plane orientation on the basis of three-dimensional analysis of the entire dividing progenitors. As shown previously 45, 46 , the majority of WT RGPs at E15.5 divided with axes that were vertical relative to the VZ surface (the angle between the cleavage plane and the VZ surface was between 60° and 90°; Fig. 7c ), whereas IPs divided with a random cleavage plane orientation (Fig. 7c) . In contrast, the cleavage plane orientation of progenitors including RGPs, regardless of their localization, in the Sas-4 −/− ; p53 −/− cortex appeared to be random (Fig. 7c) . Together, these results suggest that the centrosome is required for normal orientation of the mitotic spindle and the cleavage plane in dividing RGPs. However, these results also argue that the cleavage plane orientation is not essential for RGP asymmetric division and self-renewal. Furthermore, given that neuron number and corticogenesis appeared to be grossly normal in Sas-4 −/− ; p53 −/− cortex, our results suggest that the cleavage plane orientation of RGPs is not an essential determinant of neurogenesis in the developing cortex. a r t I C l e S
DISCUSSION
We used a conditional null allele of Sas-4 to compare RGP behavior and cortical neurogenesis in the presence and absence of centrioles. We found that deletion of Sas-4 in RGPs led to loss of centrioles, which triggered delocalization of RGPs from the VZ, progenitor mitotic delay, p53-dependent cell death, neuronal loss and microcephaly. The underlying cause of microcephaly has been investigated in a number of mouse models, including partial loss-of-function of Cdk5rap2 (MCPH3/centrosomin) 18 and Sas-4/Cenpj 19 mutants. For example, Sas-4 hypomorphic mice exhibit dwarfism from birth, as well as mild microcephaly resulting from cell death associated with genomic instability and DNA damage 19 . A similar link between aneuploidy-linked cell death and microcephaly phenotype was observed in a mouse model that overexpressed the centriole duplication protein Polo-like kinase 4 (PLK4) 20 . In comparison, we observed no substantial increase in aneuploidy or DNA damage in the Sas-4 −/− ; p53 −/− brain. Instead, our data suggested that mitotic delay in progenitors that lack the centrosome(s) leads to wide-scale p53 activation, cell death and eventually microcephaly.
Although some apoptosis during embryonic brain development has also been observed in other mouse models of microcephaly [18] [19] [20] , the microcephaly has generally been attributed to an increased rate of cell cycle exit and premature differentiation 18, 38, 47 . It has also been suggested that the depletion of neural progenitors is caused by spindle abnormalities and changes in the cleavage plane orientation 18, 47 . Even though the cleavage plane orientation was abnormal in Sas-4 −/− ; p53 −/− brains, they were not microcephalic, arguing that the cleavage plane orientation defect arising from the absence of centrosomes is not the main cause of microcephaly. Although it is possible that mutations of different centrosomal proteins result in distinct cellular defects and microcephaly [18] [19] [20] , our study suggested that p53-dependent cell death is likely to be a key cause of centrosome-associated microcephaly. Future characterization of this cell death pathway in vivo will provide crucial new information about p53 regulation and its relationship to microcephaly.
The VZ has long been thought of as a proliferative niche in the developing cortex 37 , in which the centrosome helps to anchor the RGPs 35, 38 . Our results support the hypothesis that the centrosome is required to maintain RGPs in the VZ. However, in contrast with earlier reports of RGPs losing their proliferative capacity and differentiating when they exit the VZ 35, 38 , we found that ~50% of RGPs outside of the VZ in Sas-4 −/− cortex were eliminated through p53-dependent apoptosis. When apoptosis was prevented by simultaneous removal of p53, these ectopic RGPs continued to divide and produced a normal number of IPs and neurons, despite having lost both the direct contact with the ventricular cerebrospinal fluid and the orientation of their cleavage plane relative to the VZ surface. Although ectopic RGPs arise from RGPs in the VZ and retain asymmetric division and selfrenewal capability, they are not oRGs; instead, on the basis of their morphology, mitotic behavior and marker expression, they are displaced RGPs with a unique morphology. Thus, our data suggest that the VZ, the progenitor morphology and the cleavage plane orientation are not essential for RGP asymmetric division and self-renewal. The displaced RGPs have an intrinsic program of proliferation and differentiation that can be executed outside the VZ with non-characteristic morphology and mitotic spindle orientation, as suggested by previous npg a r t I C l e S studies of isolated cortical progenitors in vitro 48 and embryonic stem cells in culture 49, 50 . Although it is likely that there are additional aspects of neuronal differentiation and cortical organization, such as neuronal migration and precise lamination, that depend on the centriole/centrosome, our findings define the principal functions of the centriole in RGPs during neocortical neurogenesis and reveal the robust plasticity of RGPs in the developing cortex in vivo.
METhODS
Methods and any associated references are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
ONLINE METhODS
Animals. The Sas-4 conditional allele was recently described 21 . In brief, knockout-first ES cell line (EPD0028_7_G05) was obtained from the International Knockout Mouse Consortium (Cenpj tm1a(EUCOMM)Wtsi ) (http:// www.mousephenotype.org/). Actin-FLP transgenic mice (JAX stock #005703) were used to excise the gene trap and obtain Sas-4 +/loxP . Nestin-Cre (JAX stock #003771), Emx1-Cre (JAX stock #005628), Ai9/tdTomato (JAX stock #007909) mice were obtained from the Jackson Laboratory. Trp53 ftm1Brn mice were a kind gift from D. Solit at SKI (JAX stock #008462). The analysis was performed in a mixed FVB/NJ and C57BL6 mouse background. Genotyping was carried out using standard PCR protocols. All experiments were conducted in accordance with animal protocols approved by the Institutional Animal Care and Use Committee of Memorial Sloan-Kettering Cancer Center.
In utero retrovirus injection. Moloney murine leukemia retroviruses were produced as previously described 51 . In utero intraventricular injection was performed as previously described 51 . In brief, uterine horns of pregnant mice at E11.5 gestation stages were exposed in a clean environment. Retrovirus solution (~1.0 µL) mixed with fast green (2.5 mg ml −1 , Sigma) was injected into the lateral ventricle through a beveled, calibrated glass micropipette (Drummond Scientific). During the procedure, the embryos were constantly bathed with warm phosphate-buffered saline (PBS, pH 7.4). After injection, the uterus was placed back in the abdominal cavity and the wound was surgically sutured. After surgery, the animal was placed in a 28 °C recovery incubator under close monitoring until it recovered and resumed normal activity.
Brain sections, immunohistochemistry, diI labeling and confocal imaging.
For analysis of brain sections, timed pregnant females that carried the Sas-4 and p53 conditional alleles and the Nestin-Cre transgene were anesthetized, embryos were removed and perfused with ice-cold PBS, followed by 4% paraformaldehyde (wt/vol) and prepared for cryosectioning or vibratrome sectioning and immunohistochemistry as previously described 52 . The following antibodies were used: rabbit antibody to ARL13B as previously described 45 , rabbit antibody to SAS-4 (a gift from P. Gönczy, Institut Suisse de Recherches Experimentales sur le Cancer; 1:1,000), rabbit antibody to CUX1 (Santa Cruz, sc-13024, 1:100), rat antibody to CTIP2 (Abcam, ab18465, 1:500), rabbit antibody to PHH3 (Millipore, 06-570, 1:500), goat antibody to FOXP2 (Santa Cruz, sc-21069, 1:100), rabbit antibody to SATB2 (Abcam, ab92446, 1:500), rabbit antibody to TBR2 (Abcam, ab23345, 1:500), rabbit antibody to PCNT (BioLegend, prb-432c, 1:500), mouse antibody to PCNT (BD Transduction Labs, 611814, 1:500), rabbit antibody to PAX6 (Biolegend, prb-278p, 1:500), mouse antibody to PAX6 (Developmental Hybridoma Bank, 1:100), rabbit antibody to CASP3 (Promega, G7481, 1:200), rabbit antibody to p53 (Leica Microsystems, p53-CM5p, 1:200), mouse antibody to Ki67 (BD Transduction Laboratories, 610968, 1:200), rabbit antibody to Ki67 (Abcam, ab16667, 1:500), rabbit antibody to SOX2 (Millipore, AB5603, 1:500), rabbit antibody to BLBP (Abcam, ab32423, 1:500), mouse antibody to P-VIMENTIN (Abcam, ab22651, 1:500), rat antibody to BrdU (Accurate, YSRTMCA2060GA, 1:500), rabbit antibody to γ-H2AX (Cell Signaling, 9718, 1:200), mouse antibody to tyrosinated α-TUBULIN (Sigma, T9028, 1:1,000) and rat antibody to EGFP (Nacalai Tesque, GF090R, 1:1,000). Alexa fluor 488-, 546-or 647-conjugated secondary antibodies (Life Technologies) were used. BrdU injection and staining were performed as described previously 53 , and EdU staining was performed using the manufacturer's protocol (Life Technologies). DiI labeling was carried out by sprinkling small DiI crystals (Life Technologies) onto fixed E15.5 brains with the meninges removed. After incubation at 37° for 24 h, brains were sectioned on a vibratome, and stained and washed as previously described 52 , but only with solutions containing 0.3% Tween-20 (vol/vol, Sigma). Fluorescence in situ hybridization staining of brain sections was performed according to standard protocols 54 . Images were obtained using a FV1000 (Olympus), or Leica SP5, and SP8 confocal microscopes (Leica microsystems). Confocal images were analyzed using Volocity software package (Improvision), Photoshop (Adobe) and ImageJ (US National Institutes of Health).
Quantification and statistical analysis. For the measurement of telencephalic area, a single cerebral hemisphere was traced from a dorsally oriented wholemount image. For relative thickness of cortical layers, the thickness of the major layer (that is, CUX1 + or CTIP2 + ) was measured relative to the overall thickness of the cortex (from the pial surface to the white matter). For cell counts in cortical layers, all cells in a 250-µm-wide columnar area from the white matter to the pial surface were counted. For cell counts of embryonic progenitors, all cells in a 250-µm-wide columnar area from the ventricular surface to the pial surface were counted. For centrosomal and primary cilia to nuclei ratio quantification, the total PCNT or ARL13B puncta along 50 µm of the VZ surface of the ventricle was counted in relation to the overlying nuclei (DAPI) in the VZ. For extra-VZ quantification, the total PCNT or ARL13B puncta in a 50 µm 2 area were counted in relation to total nuclei in the area. The cleavage plane orientation was defined by the angle between the ventricular surface and the cleavage plane. Morphology of cells was defined as follows: bipolar, two processes in the direction of the pial and apical surface; unipolar, a single process in the direction of the pial surface; multipolar, more than two visible processes (with or without a prominent process oriented toward the pial surface). Any cell that the morphology was not clearly visible was excluded from analysis.
Animals were assigned to groups on the basis of genotype. Age-matched littermates were used as controls in all experiments. No randomization was used and no animals were excluded from analyses. No statistical methods were used to predetermine sample sizes. Each experiment was done by analyzing at least three different brains. Our sample sizes are similar to those reported in a previous publication 21 . For all experiments, data distribution was assumed to be normal, but this was not formally tested. Two groups of data were assessed for significant differences using a two-tailed unpaired Student's t-test with a cutoff for significance of P < 0.05 (Prism software, GraphPad). The data are presented as the mean ± s.d.
A Supplementary methods checklist is available. 
